News

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Top FDA vaccine official rejected broad use of Covid-19 shots, documents show
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
We've Lowered Our Moat Rating for Pfizer to Narrow, Driven by Portfolio Setbacks and Policy Risk
We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...
Republicans subpoena former Pfizer exec over timing of COVID vaccine clinical tests
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
Pfizer scientist subpoenaed over claims COVID vax testing was ‘deliberately’ slowed before 2020 election
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...
The Lancet2d
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
Vaccine effectiveness studies have not differentiated the effect of the delta (B.1.617.2) variant and potential waning immunity in observed reductions in effectiveness against SARS-CoV-2 infections.